Fager and Gutierrez receive VA Career Development Awards
Two faculty in the Department of Medicine have received Career Development Awards from the U.S. Department of Veterans Affairs.
Greene and Xu receive 2021 Chair's Research Awards
Stephen Greene, MD, and Julia Xu, MD, MSc-GH, have received 2021 Chair's Research Awards from the Department of Medicine.
Oyedeji selected as 2021 Duke REACH Equity Scholar
Charity Oyedeji, MD, has received a Duke REACH Equity 2021 Career Development Award for her project "Sickle cell disease functional assessment validation and refinement (SILVR) study," with mentor JJ Strouse, MD, PhD.
Ming and Shah are part of the winning team for the HRSA Maternal and Child Health Bureau's Grand Challenge competition
David Ming, MD, and Nirmish Shah, MD, are part of the winning team for the Health Resources and Services Administration Maternal and Child Health Bureau's Grand Challenge competition for Care Coordination for Children with Special Health Care Needs.
14 Medicine faculty selected for Leadership Development for Researchers (LEADER) Program
14 faculty from the Department of Medicine have been selected for the School of Medicine Office for Faculty's 2021 LEADER program.
Shawn M. Bediako to give Phillips-Winn Memorial Medicine Grand Rounds on November 20
Shawn M. Bediako, PhD, will give the 2020 Phillips-Winn Memorial Medicine Grand Rounds virtually at 12 p.m. on Fri., Nov. 20, 2020.
At the Intersection of Sickle Cell Disease and Geriatrics with Charity Oyedeji
Charity Oyedeji, MD, a senior fellow in the Division of Hematology, is exploring the intersection of geriatrics and sickle cell disease. It’s a new field because in the past, most people with the disease did not reach adulthood.
Divisions select faculty recipients for 2020 Excellence in Education Awards
The recipients of the Department of Medicine faculty Excellence in Education Awards have been announced.
Call for applications: Duke UNC-Chapel Hill Immunotherapy Training Grant
The Duke UNC-Chapel Hill Immunotherapy Training Grant (DUNC-IMTG) is accepting applications for the 2020-2021 admission cycle. DUNC-IMTG is a combined training program from the University of North Carolina at Chapel Hill and Duke University that will focus on training individuals in translational and/or clinical research focusing on tumor immunology and cellular immunotherapy. Applications are due June 15, 2020.
8 faculty from Medicine selected for the 2020 Duke Clinical Leadership Program
Eight faculty from the Department of Medicine have been selected for the 2020 Duke Clinical Leadership Program.